Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Oct 28, 7:15 AMGE HealthCare beats Q3 2026 estimates with adjusted EPS $1.34 on $5.5B revenue, raises 2026 EPS guidance to $4.95–$5.05
Index
NDX, S&P 500
Market Cap
34.79B
Enterprise Value
42.59B
Income
2.15B
Sales
21.64B
Book/sh
25.69
Cash/sh
6.31
Employees
54000
IPO
Dec 15, 2022
P/E
16.26
Forward P/E
13.98
PEG
1.40
P/S
1.61
P/B
3.00
P/C
12.19
P/FCF
18.42
EV/EBITDA
11.65
EV/Sales
1.97
Quick Ratio
0.95
Current Ratio
1.25
Debt/Eq
0.90
LT Debt/Eq
0.88
Option/Short
Yes / Yes
EPS (ttm)
4.73
EPS next Y
5.50
EPS next Q
1.55
EPS this Y
8.99%
EPS next Y
9.98%
EPS next 5Y
9.98%
EPS past 3/5Y
2.53% 0.61%
Sales past 3/5Y
3.99% 3.74%
EPS Y/Y TTM
-2.26%
Sales Y/Y TTM
6.87%
EPS Q/Q
39.11%
Sales Q/Q
7.19%
Insider Own
0.32%
Insider Trans
7.73%
Inst Own
92.22%
Inst Trans
-1.31%
ROA
5.78%
ROE
19.93%
ROIC
9.84%
Gross Margin
39.65%
Oper. Margin
14.03%
Profit Margin
9.96%
SMA20
10.37%
SMA50
12.39%
SMA200
10.20%
Trades
Shs Outstand
452.13M
Shs Float
450.24M
52W High
89.77 -14.29%
52W Low
58.75 30.96%
Volatility
2.72% 2.61%
ATR (14)
1.96
RSI (14)
74.74
Beta
0.83
Rel Volume
0.00
Avg Volume
3.49M
Volume
569
Perf Week
7.68%
Perf Month
20.26%
Perf Quarter
10.34%
Perf Half Y
26.07%
Perf YTD
-6.19%
Perf Year
2.59%
Perf 3Y
21.80%
Perf 5Y
-
Perf 10Y
-
Prev Close
76.42
Price
76.94
Change %
0.68%
Consensus
Buy
Avg. Price Target
$87.47
Implied Upside
+13.7%
Analysts13incl. previous ratings
Rating Distribution7 Buy · 6 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 20, 2026Initiated
WWolfe Research
Peer Perform
Oct 07, 2026Initiated
BCS logoBBarclays
Overweight$85+10.5%
Sep 22, 2026Initiated
NNeedham
Buy$93+20.9%
Jul 09, 2026Initiated
BMO logoBBMO Capital Markets
Market Perform$70-9.0%
Jun 23, 2026Initiated
RY logoRRBC Capital Mkts
Outperform$80+4.0%
May 21, 2026Upgrade
UBS logoUUBS
Sell → Neutral$69-10.3%
Apr 30, 2026Downgrade
GS logoGGoldman
Buy → Neutral$65-15.5%
Jan 15, 2026Downgrade
UBS logoUUBS
Neutral → Sell$77+0.1%
Oct 13, 2025Initiated
BCS logoBBarclays
Equal Weight$86+11.8%
Oct 07, 2025Downgrade
C logoCCitigroup
Buy → Neutral$83+7.9%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lobo KevinDirectorMay 22 '26Buy64.1810,000641,80014,363May 26 06:44 PM
Hochman Rodney FDirectorMay 12 '26Buy62.031,618100,3651,618May 13 04:19 PM
Yang Watkin Phoebe L.DirectorMay 08 '26Buy63.011,00063,00613,702May 11 08:16 PM
CULP H LAWRENCE JRDirectorMay 06 '26Buy61.8880,8055,000,076151,207May 07 04:14 PM
Stromberg William JDirectorMay 06 '26Buy61.691,00061,68915,330May 07 04:09 PM
SACCARO JAMESChief Financial OfficerMay 01 '26Buy60.603,310200,58587,471May 01 11:38 AM
Jimenez Frank RGC & Corporate SecretaryApr 30 '26Buy60.451,750105,78893,932Apr 30 04:21 PM
Arduini Peter JPresident and CEOApr 30 '26Buy59.924,169249,827259,424Apr 30 04:20 PM
Kenneth StacherskiFormer OfficerNov 24 '25Proposed Sale77.004,585353,045Nov 24 04:24 PM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
PresidentMr. Peter J. Arduini
M.S.Dr. Taha Kass-Hout M.D.
General Counsel & Corporate SecretaryMr. Frank R. Jimenez Esq.
President & CEO of Patient Care SolutionsMs. Jeannette Bankes
Chief Financial OfficerMr. William K. Grogan